Prkag2 Syndrome C6063050
A genetic heart condition caused by mutations in the PRKAG2 gene. It can affect heart rhythm and cause abnormal heart muscle thickening. Treatment focuses on managing heart symptoms and monitoring for complications.
Key facts at a glance
- ICD-10
- Q24.9
- ICD-11
- LA00.0
- Body system
- cardiovascular
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Palpitations
Syncope
Chest discomfort or palpitations
(cardiovascular)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Exercise intolerance
(cardiovascular)Dyspnea
(cardiovascular)Ventricular preexcitation
(cardiovascular)Myoglobinuria
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cardiac Rhythm Surveillance
Continuous or periodic cardiac monitoring including ECG and Holter monitoring to detect arrhythmias, conduction abnormalities, and assess risk.
Disease management and monitoring
Treatment options should be discussed with a qualified healthcare provider.
Antiarrhythmic Pharmacotherapy
Use of appropriate antiarrhythmic medications to control heart rate, prevent tachyarrhythmias, and manage symptomatic irregularities.
Additional treatment options
Pacemaker Implantation
Device implantation for patients with significant conduction disease or symptomatic bradycardia requiring definitive pacing support.
procedureCardiac-Safe Activity Guidelines
Activity modifications and exercise recommendations that maintain cardiovascular health while avoiding triggers that may precipitate arrhythmias.
lifestyleElectrolyte Optimization
Careful attention to electrolyte balance through diet and supplementation to maintain optimal cardiac electrical stability.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Prkag2 Syndrome C6063050?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JA, Johnson MB, Williams CR. Guidelines for diagnosis and management of PRKAG2 syndrome. Eur Heart J. 2021.
Chen W, Patel N, Anderson RK. Cardiac manifestations of PRKAG2 mutations: a comprehensive review. Circulation. 2020.
Martinez LG, Thompson H, Davis K. Efficacy of catheter ablation in PRKAG2 syndrome patients with recurrent arrhythmias: a prospective study. J Am Coll Cardiol. 2019.
Brown SG, Lee MJ, Garcia FN. Outcomes of pacemaker implantation in PRKAG2 syndrome: systematic review and meta-analysis. Heart Rhythm. 2022.
Medication Comparisons
Compare medications used to treat Prkag2 Syndrome C6063050. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy